Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

The evolution and diversity of a low complexity vaccine candidate, merozoite surface protein 9 (MSP-9), in Plasmodium vivax and closely related species.

Chenet SM, Pacheco MA, Bacon DJ, Collins WE, Barnwell JW, Escalante AA.

Infect Genet Evol. 2013 Dec;20:239-48. doi: 10.1016/j.meegid.2013.09.011. Epub 2013 Sep 14.

2.

Low genetic polymorphism of merozoite surface proteins 7 and 10 in Colombian Plasmodium vivax isolates.

Garzón-Ospina D, Romero-Murillo L, Tobón LF, Patarroyo MA.

Infect Genet Evol. 2011 Mar;11(2):528-31. doi: 10.1016/j.meegid.2010.12.002. Epub 2010 Dec 21.

PMID:
21182986
3.

Evaluation of the genetic diversity of domain II of Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) and the ensuing strain-specific immune responses in patients from Sri Lanka.

Dias S, Somarathna M, Manamperi A, Escalante AA, Gunasekera AM, Udagama PV.

Vaccine. 2011 Oct 6;29(43):7491-504. doi: 10.1016/j.vaccine.2011.07.029. Epub 2011 Jul 23.

PMID:
21784116
4.

Merozoite surface protein-9 of Plasmodium vivax and related simian malaria parasites is orthologous to p101/ABRA of P. falciparum.

Vargas-Serrato E, Barnwell JW, Ingravallo P, Perler FB, Galinski MR.

Mol Biochem Parasitol. 2002 Mar;120(1):41-52.

PMID:
11849704
5.

Lineage-specific positive selection at the merozoite surface protein 1 (msp1) locus of Plasmodium vivax and related simian malaria parasites.

Sawai H, Otani H, Arisue N, Palacpac N, de Oliveira Martins L, Pathirana S, Handunnetti S, Kawai S, Kishino H, Horii T, Tanabe K.

BMC Evol Biol. 2010 Feb 19;10:52. doi: 10.1186/1471-2148-10-52.

6.

Worldwide sequence conservation of transmission-blocking vaccine candidate Pvs230 in Plasmodium vivax.

Doi M, Tanabe K, Tachibana S, Hamai M, Tachibana M, Mita T, Yagi M, Zeyrek FY, Ferreira MU, Ohmae H, Kaneko A, Randrianarivelojosia M, Sattabongkot J, Cao YM, Horii T, Torii M, Tsuboi T.

Vaccine. 2011 Jun 10;29(26):4308-15. doi: 10.1016/j.vaccine.2011.04.028. Epub 2011 Apr 21.

7.

Direct effect of Plasmodium vivax recombinant vaccine candidates AMA-1 and MSP-119 on the innate immune response.

Bueno LL, Fujiwara RT, Soares IS, Braga EM.

Vaccine. 2008 Feb 26;26(9):1204-13. doi: 10.1016/j.vaccine.2007.12.031. Epub 2008 Jan 14.

PMID:
18242795
8.

Differential evidence of natural selection on two leading sporozoite stage malaria vaccine candidate antigens.

Weedall GD, Preston BM, Thomas AW, Sutherland CJ, Conway DJ.

Int J Parasitol. 2007 Jan;37(1):77-85. Epub 2006 Sep 25.

PMID:
17046771
9.

Differing patterns of selection and geospatial genetic diversity within two leading Plasmodium vivax candidate vaccine antigens.

Parobek CM, Bailey JA, Hathaway NJ, Socheat D, Rogers WO, Juliano JJ.

PLoS Negl Trop Dis. 2014 Apr 17;8(4):e2796. doi: 10.1371/journal.pntd.0002796. eCollection 2014 Apr.

10.
11.

Heterogeneous genetic diversity pattern in Plasmodium vivax genes encoding merozoite surface proteins (MSP) -7E, -7F and -7L.

Garzón-Ospina D, Forero-Rodríguez J, Patarroyo MA.

Malar J. 2014 Dec 13;13:495. doi: 10.1186/1475-2875-13-495.

12.

A comparative study on worldwide genetic diversity and population structure analysis of Plasmodium vivax thrombospondin-related adhesive protein (PvTRAP) and its implications for the vivax vaccine design.

Nazeri S, Mehrizi AA, Djadid ND, Zakeri S.

Infect Genet Evol. 2015 Dec;36:410-23. doi: 10.1016/j.meegid.2015.10.015. Epub 2015 Oct 23.

PMID:
26477931
13.

Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.

Rodrigues MH, Rodrigues KM, Oliveira TR, Cômodo AN, Rodrigues MM, Kocken CH, Thomas AW, Soares IS.

Int J Parasitol. 2005 Feb;35(2):185-92. Epub 2004 Dec 19.

PMID:
15710439
14.

A comparative study of the genetic diversity of the 42kDa fragment of the merozoite surface protein 1 in Plasmodium falciparum and P. vivax.

Pacheco MA, Poe AC, Collins WE, Lal AA, Tanabe K, Kariuki SK, Udhayakumar V, Escalante AA.

Infect Genet Evol. 2007 Mar;7(2):180-7. Epub 2006 Sep 28.

15.

Evidence of purifying selection on merozoite surface protein 8 (MSP8) and 10 (MSP10) in Plasmodium spp.

Pacheco MA, Elango AP, Rahman AA, Fisher D, Collins WE, Barnwell JW, Escalante AA.

Infect Genet Evol. 2012 Jul;12(5):978-86. doi: 10.1016/j.meegid.2012.02.009. Epub 2012 Mar 3.

16.

Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2.

Hoffmann EH, da Silveira LA, Tonhosolo R, Pereira FJ, Ribeiro WL, Tonon AP, Kawamoto F, Ferreira MU.

Ann Trop Med Parasitol. 2001 Mar;95(2):117-32.

PMID:
11299119
17.
18.

A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions.

Hostetler JB, Sharma S, Bartholdson SJ, Wright GJ, Fairhurst RM, Rayner JC.

PLoS Negl Trop Dis. 2015 Dec 23;9(12):e0004264. doi: 10.1371/journal.pntd.0004264. eCollection 2015 Dec.

19.
20.

Merozoite surface protein-3 alpha as a genetic marker for epidemiologic studies in Plasmodium vivax: a cautionary note.

Rice BL, Acosta MM, Pacheco MA, Escalante AA.

Malar J. 2013 Aug 21;12:288. doi: 10.1186/1475-2875-12-288.

Items per page

Supplemental Content

Write to the Help Desk